Sarepta Therapeutics (SRPT) Could Be 28% Below Fair Value As New CEO Takes Over Simply Wall St 16:18 Thu, 30 Jul
Sarepta, in search of a turnaround, taps ex-AbbVie exec Severino as CEO BioPharma Dive 17:03 Mon, 27 Jul
STAT Plus: Sarepta names Michael Severino, former Tessera CEO, as new chief executive STAT 14:54 Mon, 27 Jul
Sarepta Therapeutics Names Michael Severino As CEO; Shares Rise In Pre-Market RTT News 14:17 Mon, 27 Jul
Sarepta Therapeutics Appoints Michael Severino, M.D., Chief Executive Officer Business Wire (Press Release) 13:33 Mon, 27 Jul
Sarepta Therapeutics to Announce Second Quarter 2026 Financial Results Business Wire (Press Release) 13:31 Wed, 22 Jul
